66 filings
Page 3 of 4
8-K
daqbo ku0v5z50y4twjq
3 Mar 22
Passage Bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights
7:15am
8-K
sayvt
11 Feb 22
Passage Bio Presents New Interim Clinical Data for Patients with GM1 Gangliosidosis in Imagine-1 Study at 2022 WORLDSymposium
11:00am
8-K
0us52yhrrm9le27pokx
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
441z6p17
17 Dec 21
Passage Bio Announces Positive Interim Safety and Biomarker Data and Advances Phase 1/2 Trial of PBGM01 in GM1 Gangliosidosis
7:01am
8-K
orfsbv2bhv7uff54wec
4 Nov 21
Passage Bio Reports Third Quarter 2021 Financial Results and Provides Recent Business Highlights
8:00am
8-K
jx0idauo
1 Nov 21
Departure of Directors or Certain Officers
5:01pm
8-K
coifciu
4 Oct 21
Regulation FD Disclosure
7:31am
8-K
9j0ca1ms9w qr
5 Aug 21
Passage Bio Reports Second Quarter 2021 Financial Results and Provides Recent Business Highlights
7:01am
8-K
36x3z4d n39nw
21 Jul 21
Departure of Directors or Certain Officers
7:01am
8-K
qempyfcr
28 May 21
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
bikt6
18 May 21
Departure of Directors or Certain Officers
5:00pm
8-K
fxaf flrrq
5 May 21
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
7:00am
8-K
c7a u0kn0
22 Mar 21
Departure of Directors or Certain Officers
7:00am
8-K
vgvn3g3paso 3p
3 Mar 21
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
7:01am
8-K
xm1ehbf0rm91bkfclqz
19 Feb 21
Departure of Directors or Certain Officers
5:01pm
8-K
c9otjjph b5n
17 Feb 21
Departure of Directors or Certain Officers
5:00pm
8-K
addbc9f3pf1jwd 2z
11 Jan 21
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
7:15am
8-K
u2onvs04d4kr20
18 Dec 20
Entry into a Material Definitive Agreement
7:00am
8-K
3f6ij8awk g0i2ean
10 Nov 20
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
7:00am
8-K
w3d5 6ce1
9 Sep 20
Corporate Presentation SEPTEMBER 2020
7:00am